7-99385765-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BS1_SupportingBS2
The NM_005720.4(ARPC1B):āc.51C>Gā(p.Asn17Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,610,334 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000098 ( 0 hom., cov: 31)
Exomes š: 0.00020 ( 3 hom. )
Consequence
ARPC1B
NM_005720.4 missense
NM_005720.4 missense
Scores
4
9
6
Clinical Significance
Conservation
PhyloP100: 1.22
Genes affected
ARPC1B (HGNC:704): (actin related protein 2/3 complex subunit 1B) This gene encodes one of seven subunits of the human Arp2/3 protein complex. This subunit is a member of the SOP2 family of proteins and is most similar to the protein encoded by gene ARPC1A. The similarity between these two proteins suggests that they both may function as p41 subunit of the human Arp2/3 complex that has been implicated in the control of actin polymerization in cells. It is possible that the p41 subunit is involved in assembling and maintaining the structure of the Arp2/3 complex. Multiple versions of the p41 subunit may adapt the functions of the complex to different cell types or developmental stages. This protein also has a role in centrosomal homeostasis by being an activator and substrate of the Aurora A kinase. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.397295).
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000985 (15/152342) while in subpopulation SAS AF= 0.000414 (2/4828). AF 95% confidence interval is 0.0000729. There are 0 homozygotes in gnomad4. There are 9 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARPC1B | NM_005720.4 | c.51C>G | p.Asn17Lys | missense_variant | 2/10 | ENST00000646101.2 | NP_005711.1 | |
ARPC1B | XM_024446628.2 | c.51C>G | p.Asn17Lys | missense_variant | 2/10 | XP_024302396.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARPC1B | ENST00000646101.2 | c.51C>G | p.Asn17Lys | missense_variant | 2/10 | NM_005720.4 | ENSP00000496599 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152224Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
15
AN:
152224
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000248 AC: 60AN: 241936Hom.: 1 AF XY: 0.000290 AC XY: 38AN XY: 131014
GnomAD3 exomes
AF:
AC:
60
AN:
241936
Hom.:
AF XY:
AC XY:
38
AN XY:
131014
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000198 AC: 289AN: 1457992Hom.: 3 Cov.: 31 AF XY: 0.000236 AC XY: 171AN XY: 724960
GnomAD4 exome
AF:
AC:
289
AN:
1457992
Hom.:
Cov.:
31
AF XY:
AC XY:
171
AN XY:
724960
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152342Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74482
GnomAD4 genome
AF:
AC:
15
AN:
152342
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 17 of the ARPC1B protein (p.Asn17Lys). This variant is present in population databases (rs142972568, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ARPC1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1464016). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ARPC1B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.;T;T;T;.;T;.;T;T;T;T;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;.;.;.;D;D;D;.;.;.;.;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
.;.;.;M;M;M;.;.;.;M;M;M;M;M
MutationTaster
Benign
N;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;D;D;.;D;D;D;D;D;D;D;D;D;.
REVEL
Uncertain
Sift
Uncertain
.;D;D;.;D;D;D;.;D;D;D;D;D;.
Sift4G
Uncertain
.;D;D;.;D;D;D;D;D;D;D;D;D;.
Polyphen
1.0
.;.;.;D;D;D;.;.;.;D;D;D;D;D
Vest4
0.93
MutPred
0.72
.;Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);Gain of methylation at N17 (P = 0.0225);
MVP
0.70
MPC
1.3
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at